Intake & Induction

Provides a list of forms that must be signed, information that should be recorded for each patient (including current medications and allergies), and tests and labs that should be drawn during the intake assessment.

Presents a sample intake questionnaire for patient treatment-planning questions.

Provides information for nurses and other clinical support staff who assist with buprenorphine induction and maintenance.

Reviews three FDA-approved medications for OUD treatment (methadone, naltrexone, and buprenorphine) and the other strategies and services needed to support people in recovery.

Assesses patients' treatment needs and whether they would be good candidates for office-based opioid treatment.

Provides a sample treatment contract for office-based opioid addiction treatment with buprenorphine.

Provides a sample treatment agreement for buprenorphine/Naloxone.

Provides a sample treatment agreement for buprenorphine/naloxone.

Highlights criteria and patient history for those requesting to transfer from methadone to office-based buprenorphine treatment.

Provides a sample consent for treatment with buprenorphine/naloxone.